Meeting
2017 ASCO Annual Meeting
Association of T-cell infiltration assessed in pretherapeutic biopsies (PTB) of patients with locally advanced rectal adenocarcinoma (LARC) with tumor response and relapse after chemoradiotherapy (CRT) and rectal surgery.
Authors
Marc Van Den Eynde
Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
Marc Van Den Eynde , Carine El Sissy , Amos Kirilovsky , Florence Marliot , Nacilla Haicheur , Cristina Anca Dragean , Etienne Danse , Marie-Armelle Denis , Alex Kartheuser , Christophe Remue , Daniel Leonard , Radu Bachman , Pamela Baldin , Astrid Decuyper , Yves Humblet , Pierre Scalliet , Anne Jouret-Mourin , Jerome Galon , Franck Pages
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3599)
DOI
10.1200/JCO.2017.35.15_suppl.3599
Abstract #
3599
Poster Bd #
222
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Total neoadjuvant treatment without surgery for locally advanced rectal cancer: Prospective study to assess tumor response, circulating genetic, and epigenetic biomarkers, and stromal transcriptome to interpret clinical outcome (NO-CUT trial).
First Author: Salvatore Siena
Poster
2018 Gastrointestinal Cancers Symposium
VOLTAGE: Multicenter phase 1b/II study of nivolumab monotherapy and subsequent radical surgery after preoperative chemoradiotherapy with capecitabine in patients with locally advanced rectal cancer.
First Author: Yuichiro Tsukada
Poster
2014 Gastrointestinal Cancers Symposium
Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC).
First Author: Simon Gollins
Poster
2024 ASCO Annual Meeting
Neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: Pooled results analysis from two prospective single-arm phase 2 trials.
First Author: Lin Gui